±èÀçÀ± º¯È£»ç
¹ý¹«¹ýÀÎ ¸í°æ(¼¿ï)ÀÇ ¾à±¹°ü·Ã Àü¹® ¹ý·ü¼ºñ½ºÀÔ´Ï´Ù.
¾à·Â
- ¼¿ï Àá½Ç°íµîÇб³
¿¬¼¼´ëÇб³ ¹ýÇаú
Á¦52ȸ »ç¹ý½ÃÇè ÇÕ°Ý
Á¦42±â »ç¹ý¿¬¼ö¿ø ¼ö·á
¹ý¹«¹ýÀÎ ¸í°æ(¼¿ï) ´ëÇ¥º¯È£»ç
Á¤ÇÏ¿¬ º¯È£»ç
¹ý¹«¹ýÀÎ ¸í°æ(¼¿ï)ÀÇ ¾à±¹°ü·Ã Àü¹® ¹ý·ü¼ºñ½ºÀÔ´Ï´Ù.
¾à·Â
- µ¿±¹´ëÇб³ »ç¹ü´ëÇÐ ºÎ¼Ó °íµîÇб³
¿¬¼¼´ëÇб³ ¹ýÇаú
¾ÆÁÖ´ëÇб³ ¹ýÇÐÀü¹®´ëÇпø
¼¿ïƯº°½Ã °øÀͺ¯È£»ç
¹ý¹«¹ýÀÎ ¸í°æ(¼¿ï) ¡º¾à±¹º¯È£»ç ´åÄÄ¡» ÁÖ°üº¯È£»ç
¹Ú¼º±Ù º¯È£»ç
¹ý¹«¹ýÀÎ ¸í°æ(¼¿ï)ÀÇ ¾à±¹°ü·Ã Àü¹® ¹ý·ü¼ºñ½ºÀÔ´Ï´Ù.
¾à·Â
- ÀÎõ ºÎ±¤°íµîÇб³ Á¹¾÷
¼º±Õ°ü´ëÇб³ ½Å¹®¹æ¼ÛÇаú Á¹¾÷
°Ç±¹´ëÇб³ ¹ýÇÐÀü¹®´ëÇпø Á¹¾÷
Çå¹ýÀçÆÇ¼Ò ½Ç¹«
¹ý¹«¹ýÀÎ ¸í°æ(¼¿ï) ¡º¾à±¹º¯È£»ç ´åÄÄ¡» ÁÖ°üº¯È£»ç
¾à±¹°³¼³ÇàÁ¤½ÉÆÇ
µî·Ï : 2020-08-07 06:54:19 |
Á¶È¸ : 5,676 |
ÇØ°á
¾È³çÇϼ¼¿ä ¾îÁ¦ ÀÎõ¿¡¼ ¾à±¹°³¼³¿©ºÎ Áú¹®ÇÑ ¾à»çÀÔ´Ï´Ù.
º¸°Ç¼Ò´ã´çÀÚ°¡ °ÅÀý»çÀ¯¸¦ À̸ÞÀÏ·Î º¸³ÂÀ¾´Ï´Ù. ÇàÁ¤½ÉÆÇÀ» ÇؾßÇÒ°Í°°Àºµ¥ ºñ¿ëÀº¾ó¸¶°¡µé°í
±â°£Àº¾î´ÀÁ¤µµ°É¶ö±î¿ä? º¯È£»ç´Ô²² ÀÇ·Ú¸¦ ÇÏ°ÔµÇ¸é ºñ¿ëÀº ¾î´ÀÁ¤µµµÇ³ª¿ä?
Ȥ½Ã ºñ½ÁÇÑ»ç·Ê°¡ ÀÖ´ÂÁö ÆǷʸ¦ º¼¼öÀÖ´Â ¹æ¹ýÀº ¾øÀ»±î¿ä?
´äº¯ºÎŹµå¸³´Ï´Ù. °¨»çÇÕ´Ï´Ù.
¾à±¹º¯È£»ç ´åÄÄ´ÔÀÇ ´äº¯ÀÔ´Ï´Ù
µî·Ï : 2020-08-07 10:18:51
¡®¾à±¹º¯È£»ç ´åÄÄ¡¯ ±èÀçÀ± º¯È£»ç :
<Ãß°¡Áú¹®> ¾È³çÇϼ¼¿ä ¾îÁ¦ ÀÎõ¿¡¼ ¾à±¹°³¼³¿©ºÎ Áú¹®ÇÑ ¾à»çÀÔ´Ï´Ù.
º¸°Ç¼Ò´ã´çÀÚ°¡ °ÅÀý»çÀ¯¸¦ À̸ÞÀÏ·Î º¸³ÂÀ¾´Ï´Ù. ÇàÁ¤½ÉÆÇÀ» ÇؾßÇÒ°Í°°Àºµ¥ ºñ¿ëÀº¾ó¸¶°¡µé°í
±â°£Àº¾î´ÀÁ¤µµ°É¶ö±î¿ä? º¯È£»ç´Ô²² ÀÇ·Ú¸¦ ÇÏ°ÔµÇ¸é ºñ¿ëÀº ¾î´ÀÁ¤µµµÇ³ª¿ä?
Ȥ½Ã ºñ½ÁÇÑ»ç·Ê°¡ ÀÖ´ÂÁö ÆǷʸ¦ º¼¼öÀÖ´Â ¹æ¹ýÀº ¾øÀ»±î¿ä?
------------------------------------------------------------------------------------------
ÆǷʸ¦ ã¾Æº¸½Ã´Â °ÍÀº ´ë¹ý¿ø Á¾ÇÕ¹ý·üÁ¤º¸ »çÀÌÆ® µîÀ» ÀÌ¿ëÇϽðųª ´ë¹ý¿ø µµ¼°ü¿¡¼ °Ë»ö °¡´ÉÇÕ´Ï´Ù.
´Ù¸¥ ¹®ÀÇ´Â À¯¼± »ó ¾È³» µµ¿Íµå¸®°Ú½À´Ï´Ù.
ÆòÀÏ 9½Ã~19½Ã »çÀÌ¿¡ 02-549-8577·Î ÀüÈÁֽŠµÚ µ¥Àϸ®ÆÊ¿¡ Áú¹® ¿Ã¸®¼Ì´Ù°í ¸»¾¸ÇØÁÖ½Ã¸é µË´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
ÀÌÀü ´äº¯ Âü°í :
http://www.dailypharm.com/Users/Knowledge/question.html?mode=View&Type=A&Kind=70&ID=21144&Search=&nPage=&returnAddr=/Users/Knowledge/Section.html?mode=View&Kind=70
µ¥Àϸ®ÆÊ-ÆʾÆÄ«µ¥¹Ì¿¡ ¿ÀÇÂÇÑ "¾à»ç°¡ ¾Ë¾Æ¾ß ÇÒ ¹ý·ü»ó½Ä 8¼±"(¾à±¹º¯È£»ç ´åÄÄ) °ÀÇ Áß
Á¦7° "ÆǷʸ¦ ÅëÇØ ¾Ë¾Æº¸´Â ¾à±¹ °³¼³À̽´"¸¦ Âü°íÇÏ½Ã¸é ´õ¿í dz¼ºÇÑ Á¤º¸¸¦ ¾òÀ¸½Ç ¼ö ÀÖ½À´Ï´Ù.
http://edu.dailypharm.com/study/studyView.html?ID=644